Francesco Claudio Stingo

Francesco Claudio Stingo

Auto-generated profile, based on publicly available information

Francesco Claudio Stingo

University of Florence

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2016 in Blood
Verified
Journal Article
Open access
PDF file
PTPhilip A. Thompson
Philip A. Thompson
CTConstantine S. Tam
Constantine S. Tam
SOSusan M. O’bRien
Susan M. O’bRien
WWWilliam G. Wierda
William G. Wierda
FSFrancesco Stingo
Francesco Stingo
MKMichael J. Keating
Michael J. Keating
Key Points: FCR-treated chronic lymphocytic leukemia patients with mutated IGHV gene achieve long-term PFS, with a plateau on the PFS curve. MRD-negativity posttreatment is highly predictive of long-term PFS, particularly in patients with mutated IGHV gene.

3 April 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
XFXenia Fave
Xenia Fave
LZLifei Zhang
Lifei Zhang
Jinzhong YangJinzhong Yang
Jinzhong Yang
DMDennis Mackin
Dennis Mackin
PBPeter Balter
Peter Balter
LCLaurence Edward Court
Laurence Edward Court
Radiomics is the use of quantitative imaging features extracted from medical images to characterize tumor pathology or heterogeneity. Features measured at pretreatment have successfully predicted patient outcomes in numerous cancer sites. This project was designed to determine whether radiomics features measured from non–small cell lung cancer (NSCLC) change during therapy and whether those features (delta-radiomics features) can improve prognostic models. Features were calculated from pretreatment and weekly intra-treatment computed tomography images for 107 patients with stage III NSCLC. Pretreatment images were used to determine feature-specific image preprocessing. Linear mixed-effects models were used to identify features that changed significantly with dose-fraction. Multivariate models were built for overall survival, distant metastases, and local recurrence using only clinical factors, clinical factors and pretreatment radiomics features, and clinical factors, pretreatment radiomics features, and delta-radiomics features. All of the radiomics features changed significantly during radiation therapy. For overall survival and distant metastases, pretreatment compactness improved the c-index. For local recurrence, pretreatment imaging features were not prognostic, while texture-strength measured at the end of treatment significantly stratified high- and low-risk patients. These results suggest radiomics features change due to radiation therapy and their values at the end of treatment may be indicators of tumor response.

2 January 2015 in Journal of the American Statistical Association
Verified
Journal Article
Closed access
CPChristine Peterson
Christine Peterson
FSFrancesco C. Stingo
Francesco C. Stingo
MVMarina Vannucci
Marina Vannucci
In this article, we propose a Bayesian approach to inference on multiple Gaussian graphical models. Specifically, we address the problem of inferring multiple undirected networks in situations where some of the networks may be unrelated, while others share common features. We link the estimation of the graph structures via a Markov random field (MRF) prior, which encourages common edges. We learn which sample groups have a shared graph structure by placing a spike-and-slab prior on the parameters that measure network relatedness. This approach allows us to share information between sample groups, when appropriate, as well as to obtain a measure of relative network similarity across groups. Our modeling framework incorporates relevant prior knowledge through an edge-specific informative prior and can encourage similarity to an established network. Through simulations, we demonstrate the utility of our method in summarizing relative network similarity and compare its performance against related methods. We find improved accuracy of network estimation, particularly when the sample sizes within each subgroup are moderate. We also illustrate the application of our model to infer protein networks for various cancer subtypes and under different experimental conditions.

20 July 2015 in Cancer
Verified
Journal Article
Open access
PDF file
PTPhilip A. Thompson
Philip A. Thompson
SOSusan M. O'BRien
Susan M. O'BRien
WWWilliam G. Wierda
William G. Wierda
AFAlessandra Ferrajoli
Alessandra Ferrajoli
FSFrancesco Stingo
Francesco Stingo
MKMichael J. Keating
Michael J. Keating
BACKGROUND: Ibrutinib is active in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). In patients treated with ibrutinib for R/R CLL, del(17p), identified by interphase fluorescence in situ hybridization (FISH), is associated with inferior progression‐free survival despite equivalent initial response rates. Del(17p) is frequently associated with a complex metaphase karyotype (CKT); the prognostic significance of CKT in ibrutinib‐treated patients has not been reported.METHODS: This study reviewed 88 patients treated for R/R CLL at The University of Texas MD Anderson Cancer Center with investigational ibrutinib‐based regimens from 2010 to 2013. Pretreatment FISH and lipopolysaccharide‐stimulated metaphase cytogenetic analysis were performed on bone marrow.RESULTS: An adequate pretreatment metaphase karyotype was available for 56 of the 88 patients. The karyotype was complex in 21 of the 56 cases; 17 of the 21 had del(17p) according to FISH. The overall response rate, including partial remission with persistent lymphocytosis, was 94%; 18% had complete responses. In a multivariate analysis (MVA), only CKT was significantly associated with event‐free survival (EFS; hazard ratio [HR], 6.6 [95% CI 1.7‐25.6]; P = .006). Fludarabine‐refractory CLL (HR, 6.9 [95% CI 1.8‐27.1], P = .005) and CKT (HR 5.9 [95% CI 1.6‐22.2], P = .008) were independently associated with inferior overall survival (OS) in MVA. Del(17p) by FISH was not significantly associated with EFS or OS in MVA.CONCLUSIONS: CKT is a powerful predictor of outcomes for ibrutinib‐treated patients with R/R CLL and may be a stronger predictor of biological behavior than del(17p) by FISH. Because of their relatively poor outcomes, patients with CKT are ideal candidates for studies of consolidative treatment strategies or novel treatment combinations. Cancer 2015 © 2015 American Cancer Society. Cancer 2015;121:3612–3621. © 2015 American Cancer Society.

24 April 2014 in Blood
Verified
Journal Article
Open access
PDF file
SWSa A. Wang
Sa A. Wang
RHRobert P. Hasserjian
Robert P. Hasserjian
PFPatricia S. Fox
Patricia S. Fox
HRHeesun J. Rogers
Heesun J. Rogers
JGJulia T. Geyer
Julia T. Geyer
AOAttilio Orazi
Attilio Orazi
Key Points: Within MDS/MPN, the WHO 2008 criteria for aCML identify a subgroup of patients with aggressive clinical features distinct from MDS/MPN-U. The MDS/MPN-U category is heterogeneous, and patient risk can be further stratified by a number of clinicopathological parameters.

14 January 2015 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
PDF file
JHJessie Y Huang
Jessie Y Huang
JKJames R Kerns
James R Kerns
JNJessica L Nute
Jessica L Nute
XLXinming Liu
Xinming Liu
PBPeter A Balter
Peter A Balter
SKStephen F Kry
Stephen F Kry
Three commercial metal artifact reduction methods were evaluated for use in computed tomography (CT) imaging in the presence of clinically realistic metal implants: Philips O-MAR, GE’s monochromatic gemstone spectral imaging (GSI) using dual-energy CT, and GSI monochromatic imaging with metal artifact reduction software applied (MARs). Each method was evaluated according to CT number accuracy, metal size accuracy, and streak artifact severity reduction by using several phantoms, including three anthropomorphic phantoms containing metal implants (hip prosthesis, dental fillings and spinal fixation rods). All three methods showed varying degrees of success for the hip prosthesis and spinal fixation rod cases, while none were particularly beneficial for dental artifacts. Limitations of the methods were also observed. MARs underestimated the size of metal implants and introduced new artifacts in imaging planes beyond the metal implant when applied to dental artifacts, and both the O-MAR and MARs algorithms induced artifacts for spinal fixation rods in a thoracic phantom. Our findings suggest that all three artifact mitigation methods may benefit patients with metal implants, though they should be used with caution in certain scenarios.